5-Chloro-2-((R)-5-methyl-[1,4]diazepan-1-yl)benzoxazole hydrochloride Cas：1266664-66-7
Pharmaceutical Materials 2025-03-02
5-Chloro-2-((R)-5-methyl-[1,4]diazepan-1-yl)benzoxazole hydrochloride, with the CAS number 1266664-66-7, is a key intermediate in the synthesis of Suvorexant, a medication used to treat insomnia. This compound features a chlorinated benzoxazole ring attached to an (R)-5-methyl-[1,4]diazepane moiety, conferring unique pharmacological properties.
It is known for its high purity and stability, making it a valuable reagent in the pharmaceutical industry. Suvorexant, as a Schedule IV controlled substance in the United States, underscores the importance of this intermediate in the development of effective sleep aids.
| Product Properties | Details |
|---|---|
| CAS Number | 1266664-66-7 |
| Chemical Name | 5-Chloro-2-((R)-5-methyl-[1,4]diazepan-1-yl)benzoxazole hydrochloride |
| Synonyms | SUVOREXANT intermediate V, (R)-5-chloro-2-(5-methyl-[1,4]diazepan-1-yl)-benzoxazole hydrochloride |
| Molecular Formula | C13H17Cl2N3O |
| Molecular Weight | 302.19958 g/mol |
| Appearance | White powder |
| Purity | ≥98% – 99% |
| CAS Registry Number | 1266664-66-7 |
| Usage | Pharmaceutical intermediate, specifically for the synthesis of Suvorexant |
,Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.
